Treatment update for allergic rhinitis

This manuscript addresses the pathogenesis of allergic rhinitis, use of nas al provocation as a method to assess inflammatory mediators and the role of cytokines, and topical glucocorticosteroids. Immunologic changes of allerg en immunotherapy, pharmacotherapy with a focus on non-sedating, and topical antihistamines are discussed. The antiinflammatory potential of fexofenadi ne, azelastine, and newer therapeutic modalities with anti-IgE are addresse d.